世界のHER2乳がん検査市場2021年ｰ2031年：検査タイプ別（免疫組織化学[IHC]、蛍光/発色insituハイブリダイゼーション[FISH/CISH]）、エンドユーザー別

• 英文タイトル：HER2 Breast Cancer Test Market (Test Type: Immunohistochemistry [IHC] and Fluorescence/Chromogenic In Situ Hybridization [FISH/CISH]; and End-user: Hospitals and Diagnostic Laboratories) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031

• レポートコード：MRC2202A052 • 出版社/出版日：Transparency Market Research / 2021年11月 • レポート形態：英文、PDF、121ページ • 納品方法：Eメール • 産業分類：医療

• 販売価格（消費税別）

Single User	￥857,660 (USD5,795)	▷ お問い合わせ
Multi User	￥1,301,660 (USD8,795)	▷ お問い合わせ
Corporate License	￥1,745,660 (USD11,795)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

Transparency Market Research社の本調査レポートは、世界のHER2乳がん検査市場を調査対象とし、序論、仮定・調査手法、エグゼクティブサマリー、市場概要、キーインサイト、検査タイプ別（免疫組織化学[IHC]、蛍光/発色insituハイブリダイゼーション[FISH/CISH]）分析、エンドユーザー別分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ）分析、競争状況など、以下の構成でまとめています。 ・序論 ・仮定・調査手法 ・エグゼクティブサマリー ・市場概要 ・キーインサイト ・世界のHER2乳がん検査市場規模：検査タイプ別（免疫組織化学[IHC]、蛍光/発色insituハイブリダイゼーション[FISH/CISH]） ・世界のHER2乳がん検査市場規模：エンドユーザー別 ・世界のHER2乳がん検査市場規模：地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ） ・競争状況

Tablet Hardness Testers Market – Scope of Report

TMR’s report on the global tablet hardness testers market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2021 to 2031. The report provides revenue of the global tablet hardness testers market for the period from 2017 to 2031, considering 2020 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global tablet hardness testers market from 2021 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the tablet hardness testers market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global tablet hardness testers market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global tablet hardness testers market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global tablet hardness testers market.

The report delves into the competitive landscape of the global tablet hardness testers market. Key players operating in the global tablet hardness testers market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global tablet hardness testers market profiled in this report.

Key Questions Answered in Tablet Hardness Testers Market Report

What is the sales/revenue generated by tablet hardness testers across all regions during the forecast period?
What are the opportunities in the global tablet hardness testers market?
What are the major drivers, restraints, opportunities, and threats in the market?
Which regional market is set to expand at the fastest CAGR during the forecast period?
Which segment is expected to generate the highest revenue globally in 2031?
Which segment is projected to expand at the highest CAGR during the forecast period?
What are the market positions of different companies operating in the global market?

Tablet Hardness Testers Market – Research Objectives and Research Approach

The comprehensive report on the global tablet hardness testers market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global tablet hardness testers market in terms of product type, function, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global tablet hardness testers market.

レポート目次

---

1. Preface
1.1. Report Scope and Market Segmentation
1.2. Research Highlights
2. Assumptions and Research Methodology
2.1. Assumptions and Acronyms Used
2.2. Research Methodology
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Global HER2 Breast Cancer Test Market Forecast
4.3. Global HER2 Breast Cancer Test Market Outlook
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunity
5. Key Insights
5.1. Revenue Model
5.2. Pricing Analysis
5.3. COVID-19 Impact Analysis
6. Global HER2 Breast Cancer Test Market Analysis, by Test Type
6.1. Introduction
6.2. Global HER2 Breast Cancer Test Market Value Share Analysis, by Test Type
6.3. Global HER2 Breast Cancer Test Market Forecast, by Test Type
6.3.1. Immunohistochemistry (IHC)
6.3.2. Fluorescence/Chromogenic In Situ Hybridization (FISH/CISH)
6.4. Global HER2 Breast Cancer Test Market Analysis, by Test Type
6.5. Global HER2 Breast Cancer Test Market Attractiveness Analysis, by Test Type
7. Global HER2 Breast Cancer Test Market Analysis, by End-user
7.1. Introduction
7.2. Global HER2 Breast Cancer Test Market Value Share Analysis, by End-user
7.3. Global HER2 Breast Cancer Test Market Forecast, by End-user
7.3.1. Hospitals
7.3.2. Diagnostic Laboratories
7.4. Global HER2 Breast Cancer Test Market Analysis, by End-user
7.5. Global HER2 Breast Cancer Test Market Attractiveness Analysis, by End-user
8. Global HER2 Breast Cancer Test Market Analysis, by Region
8.1. Introduction
8.2. Global HER2 Breast Cancer Test Market Value Share Analysis, by Region
8.3. Global HER2 Breast Cancer Test Market Forecast, by Region
8.3.1. North America
8.3.2. Europe
8.3.3. Asia Pacific
8.3.4. Latin America
8.3.5. Middle East & Africa
9. North America HER2 Breast Cancer Test Market Analysis
9.1. North America HER2 Breast Cancer Test Market Overview
9.2. North America HER2 Breast Cancer Test Market Value Share and Attractiveness Analysis, by Country
9.2.1. U.S.
9.2.2. Canada
9.3. North America HER2 Breast Cancer Test Market Value Share and Attractiveness analysis, by Test Type
9.4. North America HER2 Breast Cancer Test Market Forecast, by Test Type
9.4.1. Immunohistochemistry (IHC)
9.4.2. Fluorescence/Chromogenic In Situ Hybridization (FISH/CISH)
9.5. North America HER2 Breast Cancer Test Market Value Share and Attractiveness Analysis, by End-user
9.6. North America HER2 Breast Cancer Test Market Forecast, by End-user
9.6.1. Hospitals
9.6.2. Diagnostic Laboratories
10. Europe HER2 Breast Cancer Test Market Analysis
10.1. Europe HER2 Breast Cancer Test Market Overview
10.2. Europe HER2 Breast Cancer Test Market Value Share and Attractiveness analysis, by Country/Sub-region
10.2.1. Germany
10.2.2. U.K.
10.2.3. France
10.2.4. Italy
10.2.5. Spain
10.2.6. Rest of Europe
10.3. Europe HER2 Breast Cancer Test Market Value Share and Attractiveness Analysis, by Test Type
10.4. Europe HER2 Breast Cancer Test Market Forecast, by Test Type
10.4.1. Immunohistochemistry (IHC)
10.4.2. Fluorescence/Chromogenic In Situ Hybridization (FISH/CISH)
10.5. Europe HER2 Breast Cancer Test Market Value Share and Attractiveness Analysis, by End-user
10.6. Europe HER2 Breast Cancer Test Market Forecast, by End-user
10.6.1. Hospitals
10.6.2. Diagnostic Laboratories
11. Asia Pacific HER2 Breast Cancer Test Market Analysis
11.1. Asia Pacific HER2 Breast Cancer Test Market Overview
11.2. Asia Pacific HER2 Breast Cancer Test Market Value Share and Attractiveness Analysis, by Country/Sub-region
11.2.1. China
11.2.2. Japan
11.2.3. India
11.2.4. Australia & New Zealand
11.2.5. Rest of Asia Pacific
11.3. Asia Pacific HER2 Breast Cancer Test Market Value Share and Attractiveness analysis, by Test Type
11.4. Asia Pacific HER2 Breast Cancer Test Market Forecast, by Test Type
11.4.1. Immunohistochemistry (IHC)
11.4.2. Fluorescence/Chromogenic In Situ Hybridization (FISH/CISH)
11.5. Asia Pacific HER2 Breast Cancer Test Market Value Share and Attractiveness analysis, by End-user
11.6. Asia Pacific HER2 Breast Cancer Test Market Forecast, by End-user
11.6.1. Hospitals
11.6.2. Diagnostic Laboratories
12. Latin America HER2 Breast Cancer Test Market Analysis
12.1. Latin America HER2 Breast Cancer Test Market Overview
12.2. Latin America HER2 Breast Cancer Test Market Value Share and Attractiveness analysis, by Country/Sub-region
12.2.1. Brazil
12.2.2. Mexico
12.2.3. Rest of Latin America
12.3. Latin America HER2 Breast Cancer Test Market Value Share and Attractiveness analysis, by Test Type
12.4. Latin America HER2 Breast Cancer Test Market Forecast, by Test Type
12.4.1. Immunohistochemistry (IHC)
12.4.2. Fluorescence/Chromogenic In Situ Hybridization (FISH/CISH)
12.5. Latin America HER2 Breast Cancer Test Market Value Share and Attractiveness analysis, by End-user
12.6. Latin America HER2 Breast Cancer Test Market Forecast, by End-user
12.6.1. Hospitals
12.6.2. Diagnostic Laboratories
13. Middle East & Africa HER2 Breast Cancer Test Market Analysis
13.1. Middle East & Africa HER2 Breast Cancer Test Market Overview
13.2. Middle East & Africa HER2 Breast Cancer Test Market Value Share and Attractiveness Analysis, by Country/Sub-region
13.2.1. GCC Countries
13.2.2. South Africa
13.2.3. Rest of Middle East & Africa
13.3. Middle East & Africa HER2 Breast Cancer Test Market Value Share and Attractiveness Analysis, by Test Type
13.4. Middle East & Africa HER2 Breast Cancer Test Market Forecast, by Test Type
13.4.1. Immunohistochemistry (IHC)
13.4.2. Fluorescence/Chromogenic In Situ Hybridization (FISH/CISH)
13.5. Middle East & Africa HER2 Breast Cancer Test Market Value Share and Attractiveness Analysis, by End-user
13.6. Middle East & Africa HER2 Breast Cancer Test Market Forecast, by End-user
13.6.1. Hospitals
14. Competition Landscape
14.1. Market Player – Competition Matrix (by tier and size of companies)
14.2. Market Share Analysis, by Company, 2019
14.3. Company Profiles
14.3.1. Abbott Laboratories
14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.1.2. Product Portfolio
14.3.1.3. SWOT Analysis
14.3.1.4. Strategic Overview
14.3.2. BioGenex
14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.2.2. Product Portfolio
14.3.2.3. SWOT Analysis
14.3.2.4. Strategic Overview
14.3.3. Agilent Technologies, Inc.
14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.3.2. Product Portfolio
14.3.3.3. SWOT Analysis
14.3.3.4. Strategic Overview
14.3.4. Leica Biosystems
14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.4.2. Product Portfolio
14.3.4.3. SWOT Analysis
14.3.4.4. Strategic Overview
14.3.5. Roche
14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.5.2. Product Portfolio
14.3.5.3. SWOT Analysis
14.3.5.4. Strategic Overview
14.3.6. Mylab Discovery Solutions Pvt. Ltd.
14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.6.2. Product Portfolio
14.3.6.3. SWOT Analysis
14.3.6.4. Strategic Overview

List of Tables

Table 01: Global HER2 Breast Cancer Test Market Size (US$ Mn) Forecast, by Test Type, 2017–2031

Table 02: Global HER2 Breast Cancer Test Market Value (US$ Mn) Forecast, by Region, 2017–2031

Table 03: North America HER2 Breast Cancer Test Market Revenue (US$ Mn) Forecast, by Country, 2017–2031

Table 04: North America HER2 Breast Cancer Test Market Size (US$ Mn) Forecast, by Test Type, 2017–2031

Table 05: North America HER2 Breast Cancer Test Market Size (US$ Mn) Forecast, by End-user, 2017–2031

Table 06: Europe HER2 Breast Cancer Test Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 07: Europe HER2 Breast Cancer Test Market Size (US$ Mn) Forecast, by Test Type, 2017–2031

Table 08: Europe HER2 Breast Cancer Test Market Size (US$ Mn) Forecast, by End-user, 2017–2031

Table 09: Asia Pacific HER2 Breast Cancer Test Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 10: Asia Pacific HER2 Breast Cancer Test Market Size (US$ Mn) Forecast, by Test Type, 2017–2031

Table 11: Asia Pacific HER2 Breast Cancer Test Market Size (US$ Mn) Forecast, by End-user, 2017–2031

Table 12: Latin America HER2 Breast Cancer Test Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 13: Latin America HER2 Breast Cancer Test Market Size (US$ Mn) Forecast, by Test Type, 2017–2031

Table 14: Latin America HER2 Breast Cancer Test Market Size (US$ Mn) Forecast, by End-user, 2017–2031

Table 15: Middle East & Africa HER2 Breast Cancer Test Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 16: Middle East & Africa HER2 Breast Cancer Test Market Size (US$ Mn) Forecast, by Test Type, 2017–2031

Table 17: Middle East & Africa HER2 Breast Cancer Test Market Size (US$ Mn) Forecast, by End-user, 2017–2031

---